Journal of Pediatric Epilepsy 2023; 12(04): 130-134
DOI: 10.1055/s-0043-1768657
Case Report

Cerebellar Atrophy and Epilepsy in Twins with a Novel SCN8A Mutation

1   Clinic of Child Neurology, MHATNP “St. Naum,” Sofia, Bulgaria
2   Department of Neurology, Medical University of Sofia, Sofia, Bulgaria
,
Asya Asenova
1   Clinic of Child Neurology, MHATNP “St. Naum,” Sofia, Bulgaria
2   Department of Neurology, Medical University of Sofia, Sofia, Bulgaria
,
Tihomir Todorov
3   Genetic and Medico-Diagnostic Laboratory “GENICA,” Sofia, Bulgaria
,
Slavena Atemin
3   Genetic and Medico-Diagnostic Laboratory “GENICA,” Sofia, Bulgaria
4   Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria
,
Ales Maver
5   Clinical Institute of Medical Genetics, UMC Ljubljana, Ljubljana, Slovenia
,
Borut Peterlin
5   Clinical Institute of Medical Genetics, UMC Ljubljana, Ljubljana, Slovenia
,
Vanio Mitev
4   Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria
,
Albena Todorova
3   Genetic and Medico-Diagnostic Laboratory “GENICA,” Sofia, Bulgaria
4   Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria
,
Veneta Bojinova
1   Clinic of Child Neurology, MHATNP “St. Naum,” Sofia, Bulgaria
› Author Affiliations

Abstract

Purpose Pathogenic SCN8A variants are associated with a wide spectrum of clinical presentation, ranging from mild to severe epileptic phenotypes, cases of intellectual disability, or movement disorders without epilepsy. Ataxia and cerebellar atrophy are rarely described as components of the disease phenotype.

Case Presentation We present the cases of male twins, born after normal pregnancy and delivery, both with normal neuropsychological but with delayed motor development in the first 2 years of life. Between 8 months and 9 years of age, the boys experienced generalized tonic-clonic seizures, several times per year. When 9 years old, the children suffered an increase in seizure frequency, and the family reported gradual worsening in coordination, speech, communication, and social skills. When 9 and a half years of age, the patients were admitted to the Clinic of Child Neurology for the first time. They both had coordination syndrome (intention tremor, dysmetria, dysdiadochokinesia) that had worsened compared with previous reports, and magnetic resonance imaging of the brain showed cerebellar atrophy. The genetic testing confirmed a mutation c.2617G > T, p.Gly873Cys in SCN8A gene. After adding lamotrigine to valproate and levetiracetam, and adjusting the dosage of valproate and levetiracetam, we observed good seizure control accompanied by improvement in the coordination syndrome.

Conclusion The cerebellar atrophy in our patients is likely due to the underlying sodium channelopathy, as it was presented at the time of the seizure worsening, but we cannot exclude the role of the epileptic seizures as the worsening of the coordination syndrome accompanied the seizure aggravation, and the tendency toward improvement was evident after seizure control.

Note

The authors have received no payment in preparation of this manuscript. The manuscript has been read and approved by all the authors, each author believes that the manuscript represents honest work and the requirements for authorship have been met.




Publication History

Received: 10 February 2023

Accepted: 02 April 2023

Article published online:
11 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Gardella E, Møller RS. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes. Epilepsia 2019; 60 (Suppl 3): S77-S85
  • 2 Larsen J, Carvill GL, Gardella E. et al; EuroEPINOMICS RES Consortium CRP. The phenotypic spectrum of SCN8A encephalopathy. Neurology 2015; 84 (05) 480-489
  • 3 Schreiber JM, Tochen L, Brown M. et al. A multi-disciplinary clinic for SCN8A-related epilepsy. Epilepsy Res 2020; 159: 106261
  • 4 Trudeau MM, Dalton JC, Day JW, Ranum LP, Meisler MH. Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation. J Med Genet 2006; 43 (06) 527-530
  • 5 Johannesen KM, Gardella E, Encinas AC. et al. The spectrum of intermediate SCN8A-related epilepsy. Epilepsia 2019; 60 (05) 830-844
  • 6 Kalume F, Yu FH, Westenbroek RE, Scheuer T, Catterall WA. Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci 2007; 27 (41) 11065-11074
  • 7 Siekierska A, Isrie M, Liu Y. et al. Gain-of-function FHF1 mutation causes early-onset epileptic encephalopathy with cerebellar atrophy. Neurology 2016; 86 (23) 2162-2170
  • 8 Marcián V, Filip P, Bareš M, Brázdil M. Cerebellar dysfunction and ataxia in patients with epilepsy: coincidence, consequence, or cause?. Tremor Other Hyperkinet Mov (N Y) 2016; 6: 376
  • 9 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
  • 10 Karczewski KJ, Francioli LC, Tiao G. et al; Genome Aggregation Database Consortium. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020; 581 (7809): 434-443
  • 11 Kohrman DC, Smith MR, Goldin AL, Harris J, Meisler MH. A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting. J Neurosci 1996; 16 (19) 5993-5999
  • 12 Blanchard MG, Willemsen MH, Walker JB. et al. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. J Med Genet 2015; 52 (05) 330-337